SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-289035
Filing Date
2017-09-20
Accepted
2017-09-20 12:37:55
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d403532d424b4.htm 424B4 1386970
2 GRAPHIC g403532g06f77.jpg GRAPHIC 51501
3 GRAPHIC g403532g09t88_k.jpg GRAPHIC 100610
4 GRAPHIC g403532g17w17.jpg GRAPHIC 41586
5 GRAPHIC g403532g28p97.jpg GRAPHIC 49791
6 GRAPHIC g403532g35g36.jpg GRAPHIC 75045
7 GRAPHIC g403532g37g39.jpg GRAPHIC 47057
8 GRAPHIC g403532g46r88.jpg GRAPHIC 52753
9 GRAPHIC g403532g51m81.jpg GRAPHIC 104329
10 GRAPHIC g403532g60m71.jpg GRAPHIC 131764
11 GRAPHIC g403532g66w75.jpg GRAPHIC 41680
12 GRAPHIC g403532g68j25_k.jpg GRAPHIC 76220
13 GRAPHIC g403532g79m67.jpg GRAPHIC 50040
14 GRAPHIC g403532g90v48.jpg GRAPHIC 84945
15 GRAPHIC g403532g96l80.jpg GRAPHIC 49339
  Complete submission text file 0001193125-17-289035.txt   2705942
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-220085 | Film No.: 171093676
SIC: 2836 Biological Products, (No Diagnostic Substances)